awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35783451-3D289DDB-F717-4DEA-8A86-7ED6D9419042
Q35783451-3D289DDB-F717-4DEA-8A86-7ED6D9419042
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35783451-3D289DDB-F717-4DEA-8A86-7ED6D9419042
Pharmacologic inhibition of mTOR improves lapatinib sensitivity in HER2-overexpressing breast cancer cells with primary trastuzumab resistance.
P2860
Q35783451-3D289DDB-F717-4DEA-8A86-7ED6D9419042
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35783451-3D289DDB-F717-4DEA-8A86-7ED6D9419042
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
736f85f9ffb29f473613a410d45ba61c34b31338
P2860
Phosphatidylinositol 3-kinase hyperactivation results in lapatinib resistance that is reversed by the mTOR/phosphatidylinositol 3-kinase inhibitor NVP-BEZ235.